Herlander Marques

1.1k total citations
25 papers, 247 citations indexed

About

Herlander Marques is a scholar working on Pathology and Forensic Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Herlander Marques has authored 25 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Herlander Marques's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Herlander Marques is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Herlander Marques collaborates with scholars based in Portugal, Brazil and United Kingdom. Herlander Marques's co-authors include Rui Medeiros, Fátima Baltazar, Fernando Pardal, Adhemar Longatto‐Filho, Céline Pinheiro, Rui Manuel Reis, Ana Luísa Teixeira, Filipa Ventura, Teresa Pereira and Celeste Brito and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Quality of Life Research.

In The Last Decade

Herlander Marques

24 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herlander Marques Portugal 9 112 81 59 44 36 25 247
Eleonora Zanetti Italy 10 77 0.7× 31 0.4× 80 1.4× 48 1.1× 19 0.5× 29 253
Elaine Wiegert United States 7 64 0.6× 59 0.7× 76 1.3× 47 1.1× 48 1.3× 9 313
Maria Grazia Mameli Italy 7 118 1.1× 49 0.6× 115 1.9× 21 0.5× 13 0.4× 11 304
Thomas S. DeNapoli United States 6 116 1.0× 55 0.7× 72 1.2× 44 1.0× 30 0.8× 12 295
Nhu Le Canada 6 87 0.8× 57 0.7× 132 2.2× 99 2.3× 16 0.4× 7 372
Leting Zheng China 9 98 0.9× 54 0.7× 108 1.8× 32 0.7× 14 0.4× 18 317
Jacklyn Casanova United States 6 120 1.1× 18 0.2× 35 0.6× 28 0.6× 35 1.0× 9 284
Pilar Nava-Parada United States 9 100 0.9× 44 0.5× 90 1.5× 54 1.2× 12 0.3× 14 286
Sung Kim South Korea 11 159 1.4× 64 0.8× 171 2.9× 74 1.7× 20 0.6× 21 489

Countries citing papers authored by Herlander Marques

Since Specialization
Citations

This map shows the geographic impact of Herlander Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herlander Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herlander Marques more than expected).

Fields of papers citing papers by Herlander Marques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herlander Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herlander Marques. The network helps show where Herlander Marques may publish in the future.

Co-authorship network of co-authors of Herlander Marques

This figure shows the co-authorship network connecting the top 25 collaborators of Herlander Marques. A scholar is included among the top collaborators of Herlander Marques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herlander Marques. Herlander Marques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Marques, Herlander, et al.. (2021). Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives. Biomedicines. 9(12). 1934–1934. 2 indexed citations
3.
Marques, Herlander, et al.. (2021). ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort. International Journal of Molecular Sciences. 23(1). 201–201. 12 indexed citations
4.
Pereira, M. Graça, Gabriela Ferreira, Sara Monteiro›, et al.. (2020). The mediator role of unmet needs on quality of life in myeloma patients. Quality of Life Research. 29(10). 2641–2650. 10 indexed citations
5.
Oliveira, Alexandra, Joyce Aguiar, Brígida Mónica Faria, et al.. (2020). Biometrics and quality of life of lymphoma patients: A longitudinal mixed‐model approach. Expert Systems. 38(4). 2 indexed citations
6.
Afonso, Julieta, Susana Simoes‐Sousa, Fernando Schmitt, et al.. (2019). Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma – MCT1 as potential target in diffuse large B cell lymphoma. Cellular Oncology. 42(3). 303–318. 35 indexed citations
7.
Marques, Herlander, et al.. (2018). Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma. ecancermedicalscience. 12. 887–887. 5 indexed citations
8.
Monteiro, Margarida, et al.. (2017). Intracardiac mass from Burkitt's lymphoma in an immunocompromised patient: a very rare form of presentation. BMJ Case Reports. 2017. bcr–2017. 3 indexed citations
9.
Carvalho, S.M.P., et al.. (2016). Cost-effectiveness Analysis of Rituximab Maintenance Treatment in Patients With Follicular Lymphoma who Respond to First Line Induction Therapy in Portugal. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Amorim, Ricardo, Marta Viana‐Pereira, Céline Pinheiro, et al.. (2016). Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis. BMC Cancer. 16(1). 535–535. 49 indexed citations
11.
Cárcano, Flavio Mavignier, André van Helvoort Lengert, Daniel Onofre Vidal, et al.. (2016). Absence of microsatellite instability andBRAF(V600E) mutation in testicular germ cell tumors. Andrology. 4(5). 866–872. 21 indexed citations
12.
Marques, Herlander, José Guilherme de Freitas, Rui Medeiros, & Adhemar Longatto‐Filho. (2016). Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability.. PubMed. 7(3). 126–136. 1 indexed citations
13.
Cárcano, Flavio Mavignier, Daniel Onofre Vidal, André van Helvoort Lengert, et al.. (2015). Hotspot TERT promoter mutations are rare events in testicular germ cell tumors. Tumor Biology. 37(4). 4901–4907. 14 indexed citations
14.
Marques, Herlander, et al.. (2014). Cutaneous Plasmacytomas Secondary to Nonsecretory Multiple Myeloma. 1 indexed citations
15.
Marques, Herlander, Raquel Catarino, Nélson Domingues, et al.. (2012). Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin’s lymphoma is not associated with prognosis. Oncology Letters. 4(6). 1285–1289. 6 indexed citations
16.
Ventura, Filipa, et al.. (2010). Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia. Dermatology Research and Practice. 2010(1). 28–44. 22 indexed citations
17.
Almeida, António, et al.. (2010). [Recommendations for diagnosis, treatment and monitoring of chronic myeloid leukemia].. PubMed. 22(5). 537–44. 1 indexed citations
18.
Almeida, António, et al.. (2009). Recomendações para o diagnóstico, tratamento e monitorização da leucemia mielóide crónica.. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Ventura, Filipa, et al.. (2009). Sweet syndrome as the presenting symptom of hairy cell leukemia. Dermatology Online Journal. 15(2). 12–12. 12 indexed citations
20.
Marques, Herlander, et al.. (2008). FcγRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients. Cancer Genetics and Cytogenetics. 183(1). 35–40. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleonora Zanetti Breakdown of academic impact, for papers by Elaine Wiegert Breakdown of academic impact, for papers by Maria Grazia Mameli Breakdown of academic impact, for papers by Thomas S. DeNapoli Breakdown of academic impact, for papers by Nhu Le Breakdown of academic impact, for papers by Leting Zheng Breakdown of academic impact, for papers by Jacklyn Casanova Breakdown of academic impact, for papers by Pilar Nava-Parada Breakdown of academic impact, for papers by Sung Kim
Rankless by CCL
2026